Since compounded medication is not produced by the manufacturer in dosages that have been clinically tested, it's not FDA-approved
Obesity For weight loss, healthcare professionals may prescribe GLP-1 agonists for people with an initial BMI of 30 or higher or people who have a BMI of 27 or higher and at least one weight-related health condition, such as: type 2 diabetes prediabetes high blood pressure high cholesterol heart disease nonalcoholic fatty liver disease obstructive sleep apnea polycystic ovary syndrome Typically, healthcare professionals only prescribe these medications after someone has tried other weight loss methods, such as diet and exercise, without success
Discounts are available for Couples, 1st Responders, Military and Medical personnel
The guide on four weeks on semaglutide with no weight loss specifically addresses early non-response, while tirzepatide not working anymore addresses the scenario where effects diminish over time
[DOI] [PMC free article] [PubMed] 92.Hunter K, Hlscher C
Additionally, GLP-1 receptor agonists suppress glucagon secretion from pancreatic alpha cells, further helping to lower blood glucose levels